Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
PEGylated form offilgrastim .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word pegfilgrastim.
Examples
-
With additional funding from the Foundation, Dr. Weishaupt is testing an enhanced form of G-CSF called pegfilgrastim in other relevant pre-clinical models, a critical step in advancing G-CSF toward clinical trials.
-
In 2008, Neulasta (pegfilgrastim; Amgen/Kyowa Kirin) and Neupogen (filgrastim; Amgen/Kyowa Kirin) were the leading supportive care brands, with sales well over $1 billion.
-
Tjulandin SA, Barajas-Figueroa LJ, Wiens BL et al. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: A multicenter, double-blind, placebo-controlled phase III study.
CancerConsultants 2010
-
Fortunately, chemotherapy-induced neutropenia can be prevented in most patients with the use of Neulasta® (pegfilgrastim) or Neupogen® (filgrastim) - blood cell growth factors that increase white blood cell production.
CancerConsultants 2010
-
The blood cell growth factors Neulasta® (pegfilgrastim) or Neupogen® (filgrastim) can be administered to stimulate the bone marrow to increase neutrophil production.
CancerConsultants 2010
-
In 2008, Neulasta (pegfilgrastim; Amgen/Kyowa Kirin) and Neupogen (filgrastim; Amgen/Kyowa Kirin) were the leading supportive care brands, with sales well over
THE MEDICAL NEWS Editors 2010
-
In 2008, Neulasta (pegfilgrastim; Amgen/Kyowa Kirin) and Neupogen (filgrastim; Amgen/Kyowa Kirin) were the leading supportive care brands, with sales well over $1 billion.
-
In 2008, Neulasta (pegfilgrastim; Amgen/Kyowa Kirin) and Neupogen (filgrastim; Amgen/Kyowa Kirin) were the leading supportive care brands, with sales well over
THE MEDICAL NEWS Editors 2010
-
In 2008, Neulasta (pegfilgrastim; Amgen/Kyowa Kirin) and Neupogen (filgrastim; Amgen/Kyowa Kirin) were the leading supportive care brands, with sales well over $1 billion.
-
In 2008, Neulasta (pegfilgrastim; Amgen/Kyowa Kirin) and Neupogen (filgrastim; Amgen/Kyowa Kirin) were the leading supportive care brands, with sales well over $1 billion.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.